Bacterial Vaginosis Recurrence May Be Significantly Lowered At 12 Weeks With CTV-05 Following Treatment With Vaginal Metronidazole, Trial Indicates

Infectious Disease Advisor (7/20, van Paridon) reports, “CTV-05 (Lactin-V) after treatment with vaginal metronidazole was found to significantly lower the incidence of recurrence of bacterial vaginosis at 12 weeks compared with placebo, according to data...